Company news
Assembly Biosciences, Inc. news in 2021
Assembly Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.
Assembly Biosciences Presents New Data at AASLD The Liver Meeting™ Highlighting the Progress of its HBV Core Inhibitor Portfolio
November 11, 2021
Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
November 3, 2021
Assembly Biosciences Abstracts Selected for Presentation at the Upcoming AASLD The Liver Meeting®
October 31, 2021
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
October 18, 2021
Assembly Bio Announces October Conference Participation
October 5, 2021
Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158
August 31, 2021
Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development
August 17, 2021
Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
August 4, 2021
Assembly Bio Announces Key Promotions to Leadership Team
August 2, 2021
Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors
July 19, 2021
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs at the International Liver Congress™ EASL 2021
June 22, 2021
Assembly Biosciences to Present Data from HBV Core Inhibitor Programs at The International Liver Congress™ EASL 2021
June 8, 2021
Dr. Lisa Johnson-Pratt Joins Assembly Biosciences Board of Directors
May 23, 2021
Assembly Biosciences Reports First Quarter 2021 Financial Results and Recent Updates
May 5, 2021
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus
February 25, 2021
Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infection
February 24, 2021
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights
February 24, 2021
Assembly Bio Announces Upcoming Investor Events
February 18, 2021